Aspire BioPharma is trading at $8.78, up 7.60%, with no company-specific announcement identified to explain the October 15 move. - The latest company release found was its September name change announcement. - Biotech was up 2.20%, a possible tailwind, but this does not establish the cause of Aspire BioPharma’s larger move. - Broader market signals were mixed, and no reliable volume or activity figure was available.